Byrne Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,050	Closed	-$111K	–	568
2025 Q4	$111K	Buy	18,050 +17,650	+4,413%	+$191K	0.06%	208
2025 Q3	$7.37K	Sell	400 -2,563	-87%	-$41.2K	﹤0.01%	438
2025 Q2	$38.5K	Buy	+2,963	New	+$35K	0.03%	286
2025 Q1	–	Sell	-1,520	Closed	-$24.1K	–	292
2024 Q4	$25.8K	Sell	1,520 -560	-27%	-$10.5K	0.02%	257
2024 Q3	$48.3K	Buy	2,080 +240	+13%	+$5.13K	0.03%	204
2024 Q2	$45K	Sell	1,840 -220	-11%	-$6.67K	0.03%	210
2024 Q1	$69.6K	Sell	2,060 -270	-12%	-$9.57K	0.05%	183
2023 Q4	$76.3K	Sell	2,330 -940	-29%	-$22.3K	0.06%	165
2023 Q3	$84K	Sell	3,270 -230	-7%	-$7.08K	0.07%	154
2023 Q2	$100K	Sell	3,500 -700	-17%	-$19.1K	0.07%	193
2023 Q1	$101K	Sell	4,200 -2,315	-36%	-$41.5K	0.07%	177
2022 Q4	$110K	Buy	6,515 +1,995	+44%	+$34.8K	0.08%	171
2022 Q3	$67K	Buy	4,520 +370	+9%	+$6.21K	0.05%	187
2022 Q2	$74K	Buy	4,150 +150	+4%	+$2.94K	0.05%	163
2022 Q1	$108K	Buy	4,000 +910	+29%	+$23.2K	0.07%	154
2021 Q4	$114K	Buy	+3,090	New	+$126K	0.07%	153